ArticleBiomedical optics express2026
LensPlus: a high space-bandwidth optical imaging technique.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Joint feature issue inBiomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The space-bandwidth product (SBP) imposes a fundamental limitation in achieving high-resolution and large field-of-view image acquisitions simultaneously. High-NA objectives provide fine structural detail at the cost of reduced spatial coverage and slower scanning as compared to a low-NA objective, while low-NA objectives offer wide fields of view but compromised resolution. Here, we introduce LensPlus, a deep learning-based framework that enhances the SBP of quantitative phase imaging (QPI) without requiring hardware modifications. By training on paired datasets acquired with low-NA and high-NA objectives, LensPlus learns to recover high-frequency features lost in low-NA measurements, effectively bridging the resolution gap while preserving the large field of view, thereby increasing the SBP. We demonstrate that LensPlus can transform images acquired with a 10x/0.3 NA objective (40x/0.95 NA for another model) to a quality comparable to that obtained using a 40x/0.95 NA objective (100x/1.45NA for the second model), resulting in a 2D-SBP improvement of approximately 3.5x (2.04x for the second model). Importantly, unlike adversarial models, LensPlus employs a non-generative model to minimize image hallucinations and ensure quantitative fidelity as verified through spectral analysis. Beyond QPI, LensPlus is broadly applicable to other lens-based imaging modalities, enabling wide-field, high-resolution imaging for time-lapse studies, large-area tissue mapping, and applications where high-NA oil objectives are impractical.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.